Canada’s chief public health officer, Dr. Theresa Tam, announced that Pfizer-BioNTech’s COVID-19 vaccine has been authorized to be used as a booster for children aged 5-11.

BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...

The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...

BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...

Chief public health officer Dr. Theresa Tam says Health Canada is authorizing a booster dose of the Pfizer-BioNTech vaccine ...

Canada’s top doctor says the NACI recommends children with underlying health conditions be offered a COVID-19 booster no ...

BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...

Canada's health ministry said on Friday it had authorized the use of Pfizer Inc's and BioNTech's coronavirus vaccine as a ...

July 31, 2022 -- The Biden administration plans to begin a COVID-19 booster campaign with reformulated ... In late June, Pfizer-BioNTech also announced a $3.2 billion agreement with the U.S ...

4/5-containing vaccine it’s developing with BioNTech BNTX ... He told investors that Pfizer and the FDA have agreed that the application for the updated booster will include “safety and ...

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase ...

Chief public health officer Dr. Theresa Tam says Health Canada is authorizing a booster dose of the Pfizer-BioNTech vaccine for children between five and 11 years old. More coming. The ...